Document is current
Any future updates will be listed below
-
Authors
Grout, Randall W.
Ateya, Mohammad
DiRenzo, Baely
Hart, Sara
King, Chase
Rajkumar, Joshua
Sporrer, Susan
Torabi, Asad
Walroth, Todd A.
Kovacs, Richard J.
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 18 June 2024
Accepted: 18 November 2024
First Online: 18 December 2024
Declarations
:
: The final protocol and any amendments were reviewed and approved by the Indiana University institutional review board (IRB) and Eskenazi Health. The IRBs waived the requirement of signed informed consent, but patients were provided an information sheet about the study and were allowed to decline enrollment.
: Not applicable.
: R.W. Grout, R.J. Kovacs, C. King, and A. Torabi are employees of Indiana University, which received financial support from Pfizer Inc. in connection with the execution of this study. J. Rajkumar was an employee of Eskenazi Health and B. DiRenzo and T.A. Walroth are employees of Eskenazi Health, which received financial support from Pfizer Inc. in connection with the execution of this study. M. Ateya, S. Hart, and S. Sporrer are employees of Pfizer Inc.
